Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
4.720
-0.040 (-0.84%)
At close: Oct 8, 2025, 4:00 PM EDT
4.710
-0.010 (-0.21%)
After-hours: Oct 8, 2025, 7:48 PM EDT
Owens & Minor Revenue
Owens & Minor had revenue of $681.92M in the quarter ending June 30, 2025, with 3.26% growth. This brings the company's revenue in the last twelve months to $10.76B, up 64.35% year-over-year. In the year 2024, Owens & Minor had annual revenue of $10.70B with 3.55% growth.
Revenue (ttm)
$10.76B
Revenue Growth
+64.35%
P/S Ratio
0.03
Revenue / Employee
$463,726
Employees
23,200
Market Cap
364.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.70B | 366.92M | 3.55% |
| Dec 31, 2023 | 10.33B | 378.49M | 3.80% |
| Dec 31, 2022 | 9.96B | 170.16M | 1.74% |
| Dec 31, 2021 | 9.79B | 1.31B | 15.39% |
| Dec 31, 2020 | 8.48B | -730.76M | -7.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OMI News
- 1 day ago - PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR - PRNewsWire
- 1 day ago - Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake - Business Wire
- 23 days ago - Apria and Byram Join New Optum Preferred DME Network - Business Wire
- 4 weeks ago - AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 - PRNewsWire
- 2 months ago - Owens & Minor Analysts Boost Their Forecasts After Q2 Results - Benzinga
- 2 months ago - Owens & Minor: An Extreme Reached Amid Disastrous Results (Rating Upgrade) - Seeking Alpha
- 2 months ago - Owens & Minor, Inc. (OMI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - US Stocks Mixed; Owens & Minor Posts Downbeat Earnings - Benzinga